Aricept used for memory problems?

Page last modified on: June 3, 2008

Question from HVC: My primary care physician has me on Aricept for some memory problems. Is this becoming standard treatment for chemo brain, which is what he thinks caused the memory problem? I also have concerns about what insurance agencies may think about people being on such a medication in the future, and how it will affect purchasing long term care insurance, etc. Thanks.

Answer —Beth DuPree, M.D., F.A.C.S.: I do not believe that Aricept (chemical name: donepezil HCI) medication that is being used for memory problems after chemotherapy is standard practice in oncology care. This may have been a medication that your physician chose to use for you at this point in time to try and counteract some of the side effects that you may have been having in your therapy. I would certainly discuss this with your physician and I do not believe that it should affect your ability to purchase long-term insurance.

On Wednesday, September 20, 2006, our Ask-the-Expert Online Conference was called Open for Your Questions. Ruth Oratz, M.D., F.A.C.P. and moderator Beth Baughman DuPree, M.D., F.A.C.S. answered your questions covering a wide variety of issues relating to breast cancer.


The materials presented in these conferences do not necessarily reflect the views of breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.

A production of LiveWorld, Inc.
Copyright 2008. All rights reserved.

Back to top

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

Learn more about our commitment to your privacy

© 2008 Breastcancer.org - All rights reserved.

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.